The defense attorney did not hold back when addressing a group of plastic industry executives, warning them to be prepared for a surge of lawsuits with potentially massive costs. Speaking at a conference earlier this year, attorney Brian Gross emphasized that the upcoming litigation related to PFAS, also known as “forever chemicals,” could surpass even the extensive legal battles surrounding asbestos.
PFAS, which have been used in a wide range of everyday products for decades, have been linked to serious health risks, including cancer. Recent government regulations have mandated the removal of certain PFAS chemicals from the drinking water of millions of Americans.
Mr. Gross advised companies to review their marketing materials and communications for any potential liabilities and to find the right witnesses to defend their interests. The industries involved are gearing up for legal battles related to PFAS, a class of synthetic chemicals linked to significant health problems.
Lawsuits related to PFAS have already targeted major manufacturers like DuPont, Chemours, and 3M. The legal battle is expected to escalate, with more companies facing scrutiny for their use of PFAS in products. The Biden administration has taken steps to regulate these chemicals, with new rules expected to lead to further litigation.
Experts predict that the wave of PFAS-related lawsuits is just beginning, with potentially significant financial liabilities for companies. The long-lasting nature of PFAS and their widespread presence in the environment make them a major concern for public health and the legal system.
The industry’s past actions and knowledge of the risks associated with PFAS could lead to substantial legal consequences. Individuals like Sandy Wynn-Stelt have already taken legal action against companies like Wolverine and 3M for their role in PFAS contamination. The legal landscape surrounding PFAS is complex, with challenges in proving the health effects of these chemicals and holding companies accountable.
Despite some legal victories for the industry, the ongoing litigation over PFAS is expected to continue and potentially expand in the coming years. The uncertainty surrounding the health effects of PFAS and the need for long-term studies create challenges for both researchers and legal experts involved in these cases.